Photoallergic Drug Eruption Caused by Certolizumab Pegol

Fixed Drug Eruption Caused by Sildenafil Citrate

Vol. 29, No. 2, 2017 247 Received August 24, 2015, Revised April 7, 2016, Accepted for publication April 10, 2016 Corresponding author: Kui Young Park, Department of Dermatology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea. Tel: 82-2-6299-1525, Fax: 82-2-823-1049, E-mail: [email protected] This is an Open Access arti...

Fixed drug eruption caused by tadalafil - Case report*

UNLABELLED Fixed drug eruptions (FDE) are commonly reported type of mucocutaneous drug eruption. The aim of this paper is to present a patient with multiple mucocutaneous erythema fixum type lesions caused by oral tadalafil use. A short course of topical corticosteroid therapy resulted in complete resolution of all lesions leaving residual hyperpigmentation of the involved skin sites. Mucosal o...

Fixed drug eruption caused by amoxicillin-clavulanic acid.

Active axial spondyloarthritis: potential role of certolizumab pegol

The axial spondyloarthropathies are a group of chronic inflammatory diseases that predominantly affect the axial joints. This group includes ankylosing spondylitis and nonradiographic axial spondyloarthropathy. While the pathogenesis of axial spondyloarthropathies is not clear, immunologically active tissues primarily include the entheses, ie, the areas where ligaments, tendons, and joint capsu...

Certolizumab pegol for the treatment of rheumatoid arthritis.

INTRODUCTION Improved understanding of the pathogenesis of rheumatoid arthritis (RA), and subsequent development of targeted therapies, have greatly advanced the management of this chronic inflammatory disease. The aim of treatment is a state of clinical remission. Certolizumab pegol (CZP) is a novel pegylated TNF alpha inhibitor (TNFi) therapy and is the focus of this review. AREAS COVERED C...